Further substantiating the role of RUNX2 in breast cancer, Knutson et al. revealed that RUNX2 is instrumental in maintaining tumor stem cell activity, a mechanism intricately connected with phospho-progesterone receptors and EGF signaling pathways [131]. Here, RUNX2 is linked to neoplasm.